Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8223481 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 10 Pages |
Abstract
We review the evidence for optimal surgical management and adjuvant therapy for patients with stages I and II non-small cell lung cancer (NSCLC) along with factors associated with increased risks of recurrence. Based on the current evidence, we recommend optimal use of mediastinal lymph node dissection, adjuvant chemotherapy, and post-operative radiation therapy, and make suggestions for areas to explore in future prospective randomized clinical trials.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Laura MD, Malcom MD, Abram MD, John MD, Chandra P. MD, John MD,